IndraLab

Statements


SGH inhibits USP28. 4 / 4
| 1 3

reach
"In terms of the mechanism, SGH inhibits USP28 and downregulates the important cancer transcription factor c-MYC by downregulating the cell cycle and nucleotide synthesis-related proteins to block the [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"All data together indicated that the downregulation of c-Myc, HK2, PKM2, LDHA, PHGDH, PSAT1, cyclin D1, and CDK6 in lung cancer cells was related to the ubiquitin protein degradation pathway, which was the result that the USP28 was inhibited by SGH."

reach
"In terms of mechanism of action, SGH downregulated cell cycle- and nucleotide synthesis related proteins to block cell cycle at G0/G1 phase, reduced the expression levels of glycolytic metabolic enzymes to inhibit glycolysis, and downregulated the important cancer transcription factor c-Myc and the therapeutic target deubiquitinase USP28."

eidos
"All data together indicated that the downregulation of c-Myc , HK2 , PKM2 , LDHA , PHGDH , PSAT1 , cyclin D1 , and CDK6 in lung cancer cells was related to the ubiquitin-protein degradation pathway , which was the result that the USP28 was inhibited by SGH ."